Early Tumor Marker Response as a Predictor for Clinical Outcome in Patients With Advanced Gastric Cancer Undergoing Palliative Chemotherapy

被引：0
|
作者：
Cho, In Rae
Park, Jun Chul
Yoon, Ji Young
Cheoi, Kyung Seok
Lee, Hyuk
Shin, Sung Kwan
Lee, Sang Kil
Lee, Yong Chan
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S524 / S524
页数：1
相关论文
共 50 条
  • [21] Sarcopenia as a Prognostic Marker for Survival in Gastric Cancer Patients Undergoing Palliative Chemotherapy. A Systematic Review and Meta Analysis
    Meyer, Hans-Jonas
    Wienke, Andreas
    Surov, Alexey
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (10): : 3518 - 3526
  • [22] Clinical implication of DNA damage response gene in advanced gastric cancer stage IV and recurrent gastric cancer patients after gastrectomy treated palliative chemotherapy
    Hwang, I. G.
    Park, S. E.
    Kim, J. E.
    ANNALS OF ONCOLOGY, 2022, 33 : S1479 - S1479
  • [23] Clinical Implication of DNA Damage Response Genes in Advanced Gastric Cancer Stage IV and Recurrent Gastric Cancer Patients After Gastrectomy Treated Palliative Chemotherapy
    Kim, Jeong Eun
    Park, Song Ee
    Kim, Hee Jun
    Hwang, In Gyu
    JOURNAL OF CANCER, 2023, 14 (07): : 1216 - 1222
  • [24] Adapted Choi response criteria for prediction of clinical outcome in locally advanced gastric cancer patients following preoperative chemotherapy
    Liu, Kun
    Li, Guoli
    Fan, Chaogang
    Zhou, Changsheng
    Li, Jieshou
    ACTA RADIOLOGICA, 2012, 53 (02) : 127 - 134
  • [25] Tissue microRNAs as predictive markers for gastric cancer patients undergoing palliative chemotherapy
    Smid, David
    Kulda, Vlastimil
    Srbecka, Kristyna
    Kubackova, Dasa
    Dolezal, Jan
    Daum, Ondrej
    Kucera, Radek
    Topolcan, Ondrej
    Treska, Vladislav
    Skalicky, Tomas
    Pesta, Martin
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (06) : 2693 - 2703
  • [26] Clinical impact of the HGF/MET pathway activation in patients with advanced gastric cancer treated with palliative chemotherapy
    F Graziano
    V Catalano
    P Lorenzini
    E Giacomini
    D Sarti
    G Fiorentini
    M De Nictolis
    M Magnani
    A Ruzzo
    The Pharmacogenomics Journal, 2014, 14 : 418 - 423
  • [27] Clinical impact of the HGF/MET pathway activation in patients with advanced gastric cancer treated with palliative chemotherapy
    Graziano, F.
    Catalano, V.
    Lorenzini, P.
    Giacomini, E.
    Sarti, D.
    Fiorentini, G.
    De Nictolis, M.
    Magnani, M.
    Ruzzo, A.
    PHARMACOGENOMICS JOURNAL, 2014, 14 (05): : 418 - 423
  • [28] Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer
    Carruthers, R.
    Tho, L. M.
    Brown, J.
    Kakumanu, S.
    McCartney, E.
    McDonald, A. C.
    COLORECTAL DISEASE, 2012, 14 (10) : E701 - E707
  • [29] Goals of care designations in advanced pancreatic cancer patients undergoing palliative chemotherapy
    Anaka, Matthew
    Lee, Minji
    Lim, Elisa
    Ghosh, Sunita
    Cheung, Winson Y.
    Spratlin, Jennifer L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [30] Individualized Tumor Response Testing for Prediction of Response to Paclitaxel and Cisplatin Chemotherapy in Patients with Advanced Gastric Cancer
    Kim, Jee Hyun
    Lee, Keun-Wook
    Kim, Yeul Hong
    Lee, Kyung Hee
    Oh, Do Youn
    Kim, Joonhee
    Yang, Sung Hyun
    Im, Seock-Ah
    Choi, Sung Ho
    Bang, Yung-Jue
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (05) : 684 - 690
12345